DUBLIN--(BUSINESS WIRE)--The "Positron Emission Tomography (PET) Scanners - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global market for Positron ...

Investigators developed and validated new PSMA-PET-based nomograms for prognostication across prostate cancer stages to help guide management.

We surveyed oncologists who treat classic Hodgkin lymphoma (cHL) as part of the CONNECT study to understand the treatment decision‐making process, including the impact of positron emission ...

Positron emission tomography (PET) remains a cornerstone of biomedical imaging, offering a non‐invasive technique to visualise metabolic processes and molecular pathways in vivo. Central to the ...

Positron emission tomography (PET) is a type of imaging scan that doctors might use when diagnosing and treating non-Hodgkin’s lymphoma (NHL). It can be useful for identifying and staging the cancer.

Suggested Citation: "6 POSITRON EMISSION TOMOGRAPHY." National Research Council. 1996. Mathematics and Physics of Emerging Biomedical Imaging. Washington, DC: The National Academies Press. doi: ...

Positron Emission Tomography (PET) and Computed Tomography (CT) are complementary imaging modalities that have revolutionised diagnostic and research strategies in modern medicine. PET exploits the ...

Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer—Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update A re-evaluation of less than half (150 ...

- PIPE-791 achieved high LPA1 brain receptor occupancy (RO) in healthy volunteers and progressive multiple sclerosis (PrMS) patients - PIPE-791 showed a safety and tolerability profile consistent with ...

This tutorial explains how positron emission tomography (PET) imaging systems generate 3-D medical images. The article details how the PET system detects gamma-rays produced when injected doped sugars ...

YARDLEY, Pa.--(BUSINESS WIRE)--Jubilant Radiopharma’s Radiopharmacies division is excited to announce an investment of $50 million (USD) to expand its PET radiopharmaceutical manufacturing facilities ...